Measles Vaccines — Precision Vaccinations News
Measles is a vaccine-preventable disease. Measles Vaccines 2024. Measles vaccination programs began in the United States in 1963 and continue in every state and territory in 2024. The U.S. Centers for Disease Control and Prevention (CDC) published the measles vaccination schedules for children and adults and issued an alert for international travelers visiting measles outbreak areas in 2024.
Influenza Vaccines — Precision Vaccinations News
2024年10月24日 · Influenza Vaccine Clinical Trials, Effectiveness, Side Effects 2024. Influenza vaccines, known as flu shots, protect people against influenza viruses each flu season, say the U.S. Centers for Disease Control and Prevention (), the European Medicines Agency (), and the World Health Organization ().The WHO says that influenza vaccines do not cause seasonal flu since they are made with either ...
Measles Outbreaks — Precision Vaccinations News
2024年11月15日 · Measles Outbreaks 2024. The World Health Organization reported that measles outbreaks have continued throughout 2024.Over the last five years, measles outbreaks have been reported in 103 countries. There were an estimated 10.3 million measles cases in 2023, a 20% increase from 2022.. The European Centre for Disease Prevention and Control confirmed in October 2024 that measles cases were ...
Anktiva IL-15 Superagonist — Precision Vaccinations News
2024年11月20日 · Anktiva® (N-803) IL-15 Superagonist Vaccine Availability, Clinical Trials, Dosage, Side Effects. ImmunityBio, Inc. (Altor BioScience, LLC) intravesical therapy Anktiva® (N-803) (nogapendekin alfa inbakicept-pmln) is a first-in-class interleukin-15 agonist IgG1 fusion complex consisting of an IL-15 mutant fused with an IL-15 receptor alpha, which binds with high affinity to IL-15 receptors on ...
mRESVIA RSV Vaccine — Precision Vaccinations News
2024年8月25日 · mRESVIA® (mRNA-1345) RSV Vaccine Clinical Trials, Dosage, Efficacy, Side Effects. Moderna Inc.'s mRESVIA® () Respiratory Syncytial Virus messenger RNA () vaccine that encodes for a prefusion F glycoprotein and uses lipid nanoparticles (), eliciting a superior neutralizing antibody response. The prefusion conformation is a significant target of potent neutralizing antibodies, and the protein ...
Vax-Before-Travel Vaccines — Precision Vaccinations News
2024年11月23日 · Vax-Before-Travel Travel Vaccines 2024. Getting vaccinated against infectious diseases is one of the most effective ways to protect your health while traveling abroad, says the World Health Organization ().The WHO published an updated list of vaccines in October 2024. According to the U.S. Centers for Disease Control and Prevention (), most travel vaccines should be administered at least one ...
cAD3-Marburg Vaccine — Precision Vaccinations News
2024年11月1日 · cAD3-Marburg Vaccine. The cAD3-Marburg vaccine candidate is being developed by the National Institute of Allergy and Infectious Diseases (), part of the U.S. National Institutes of Health ().This vaccine uses a modified chimpanzee adenovirus, cAD3. cAD3 is not replicable, nor can it infect cells.Instead, it displays a glycoprotein found on the Marburg Virus surface to induce immune responses ...
Vaxcyte Pneumococcal Vaccines — Precision Vaccinations News
2024年11月6日 · Vaxcyte Pneumococcal Vaccines Clinical Trials, Indication, Side Effects. Vaxcyte Inc.'s carrier-sparing Pneumococcal Vaccine (PCV) franchise candidates VAX-24, a 24-valent PCV, and VAX-31, a 31-valent PCV, are being studied for the prevention of invasive pneumococcal disease ().). Both VAX-24 and VAX-31 are designed to improve upon the standard-of-care PCVs for both children and adults by ...
M72/AS01E (M72) Tuberculosis Vaccine — Precision Vaccinations …
2024年10月16日 · M72/AS01E (M72) Tuberculosis Vaccine Candidate Clinical Trials, Efficacy, Side Effects. M72/AS01E (M72) is a subunit vaccine candidate that contains the M72 recombinant fusion protein derived from two Mycobacterium tuberculosis (Mtb) antigens (Mtb32A and Mtb39A) combined with the GlaxoSmithKline plc proprietary Adjuvant System AS01.The Mtb39A and Mtb32A components of the recombinant antigen ...
Meningococcal Vaccines — Precision Vaccinations News
2024年9月23日 · Meningococcal Vaccines 2024. There are three types of meningococcal vaccines licensed by the U.S. Food and Drug Administration (FDA): Meningococcal conjugate (MenACWY) and Serogroup B meningococcal () vaccines, and Pentavalent or MenABCWY vaccine.Internationally, the European Medicines Agency and the U.K. NHS have approved vaccines such as MenQuadfi and Hib/MenC.